In the BioHarmony Drug Report Database

"Preview" Icon

Triclabendazole

Egaten (triclabendazole) is a small molecule pharmaceutical. Triclabendazole was first approved as Egaten on 2019-02-13. It is used to treat fascioliasis in the USA.

 

Trade Name

 

Egaten
 

Common Name

 

triclabendazole
 

ChEMBL ID

 

CHEMBL1086440
 

Indication

 

fascioliasis
 

Drug Class

 

Anthelmintics (tibendazole type)

Image (chem structure or protein)

Triclabendazole structure rendering